Growth Hormone Overexpression Induces Hyperphagia and Intestinal Morphophysiological Adaptations to Improve Nutrient Uptake in Zebrafish
Overview
Authors
Affiliations
The excess of circulating growth hormone (GH) in most transgenic animals implies mandatory growth resulting in higher metabolic demand. Considering that the intestine is the main organ responsible for the digestion, absorption, and direction of dietary nutrients to other tissues, this study aimed to investigate the mechanisms by which overexpression modulates the intestine to support higher growth. For this purpose, we designed an 8-weeks feeding trial to evaluate growth parameters, feed intake, and intestinal morphometric indices in the adult -transgenic zebrafish () model. To access the sensitivity of the intestine to the excess of circulating GH, the messenger RNA (mRNA) expression of intestine GH receptors (GHRs) ( and ) was analyzed. In addition, the expression of insulin-like growth factor 1a () and genes encoding for di and tripeptide transporters ( and ) were assessed. Gh-transgenic zebrafish had better growth performance and higher feed intake compared to non-transgenic sibling controls. Chronic excess of GH upregulates the expression of its cognate receptor () and the main growth factor related to trophic effects in the intestine (). Moreover, transgenic zebrafish showed an increased intestinal absorptive area and higher expression of crucial genes related to the absorption of products from meal protein degradation. These results reinforce the ability of GH to modulate intestinal morphology and the mechanisms of assimilation of nutrients to sustain the energy demand for the continuous growth induced by the excess of circulating GH.
Licitra R, Fronte B, Verri T, Marchese M, Sangiacomo C, Santorelli F Biology (Basel). 2024; 13(4).
PMID: 38666821 PMC: 11047914. DOI: 10.3390/biology13040209.
The effect of environmental stressors on growth in fish and its endocrine control.
Canosa L, Bertucci J Front Endocrinol (Lausanne). 2023; 14:1109461.
PMID: 37065755 PMC: 10098185. DOI: 10.3389/fendo.2023.1109461.
Wu Y, Li R, Wu X, Guo W, Zhong W, Li Y Front Endocrinol (Lausanne). 2022; 13:1038479.
PMID: 36561570 PMC: 9763934. DOI: 10.3389/fendo.2022.1038479.